vaccine, immunology
Ebola Survivor’s Antibodies Thwart Multiple Viral Strains
Ebola Survivor’s Antibodies Thwart Multiple Viral Strains
Kerry Grens | May 18, 2017
The antibodies bind conserved viral parts, allowing them to neutralize all five Ebola types.
Two Confirmed Cases of Ebola in Congo
Two Confirmed Cases of Ebola in Congo
Kerry Grens | May 15, 2017
More than a dozen other individuals are suspected of infection in the central African nation.
Polio Vaccine Pioneer Dies
Polio Vaccine Pioneer Dies
Kerry Grens | May 2, 2017
Julius Youngner collaborated with Jonas Salk on the polio vaccine, and later identified interferon gamma and contributed to an equine influenza vaccine.
Macrophages Physically Relay Signals Between Cell Types
Macrophages Physically Relay Signals Between Cell Types
Catherine Offord | May 1, 2017
Time-lapse imaging shows the immune cells transferring chemical signals during pigment pattern formation in developing zebrafish.
Infographic: How the Zebrafish Got Its Stripes
Infographic: How the Zebrafish Got Its Stripes
Catherine Offord | Apr 30, 2017
Immune cells called macrophages shuttle cellular messages in the skin.
Viral Trigger for Celiac Disease?
Viral Trigger for Celiac Disease?
Anna Azvolinsky | Apr 6, 2017
A common, seemingly benign human virus can trigger an immune response that leads to celiac disease in a mouse model, researchers show. 
DNA-Based Zika Vaccine Reaches Phase 2
DNA-Based Zika Vaccine Reaches Phase 2
Tracy Vence | Apr 4, 2017
An NIAID-sponsored clinical trial advances beyond safety testing.
Gel Scaffolds for Delivery of Immunotherapies
Gel Scaffolds for Delivery of Immunotherapies
Rachel Berkowitz | Apr 1, 2017
Using biocompatible polymers to carry cancer immune therapies directly to the tumor
Making CAR T-Cell Therapy Safer
Making CAR T-Cell Therapy Safer
Catherine Offord | Apr 1, 2017
Following a spate of patient deaths in clinical trials testing modified T cells for the treatment of cancer, researchers work to reduce the treatment’s toxicity without sacrificing efficacy.
Neoantigens Enable Personalized Cancer Immunotherapy
Neoantigens Enable Personalized Cancer Immunotherapy
Stephen P. Schoenberger and Ezra Cohen | Apr 1, 2017
Tumors’ mutations can encode the seeds of their own destruction, in the form of immunogenic peptides recognized by T cells.